Buy or sell Nimbus Therapeutics stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Nimbus Therapeutics Stock
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.
About Nimbus Therapeutics Stock
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
Chief Business Officer
Head of Chemistry
Co-Founder and Director
Head of Nimbus Tyk2
Chief Scientific Officer
Head of Nimbus
Head of Preclinical and Early Development
Head of Nimbus ACC
Xconomy - Jun, 5 2018
Wall Streets Journal - Jun, 5 2018
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase